Pain Management

Field testing of inferential current device for pain management completed

Published in Medical Letter on the CDC and FDA, September 18th, 2005

Zynex Medical Holdings, Inc. (ZYNX), a provider of pain management systems and electrotherapy products for medical patients with functional disability, announced it has completed field testing of its IF8100 inferential current (IFC) device that offers new treatment modalities for home use.

"The IF8100 is built on the same platform as our existing IF8000 model for treating muscle spasms and for pain management and recovery following orthopedic surgery," said Zynex president and chief executive officer Thomas Sandgaard.

Zynex is in the process of preparing the IF8100 for submission to the U.S. Food and Drug Administration (FDA) for approval.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2005-09-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry